4//SEC Filing
Thatcher Christopher 4
Accession 0001209191-19-024035
CIK 0001227636other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 6:26 PM ET
Size
9.5 KB
Accession
0001209191-19-024035
Insider Transaction Report
Form 4
Thatcher Christopher
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2019-04-08$0.87/sh+15,000$13,050→ 69,811 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-04-08−15,000→ 375,297 totalExercise: $0.87Exp: 2025-02-18→ Common Stock (15,000 underlying) - Sale
Common Stock
2019-04-08$16.82/sh−15,000$252,300→ 54,811 total
Footnotes (3)
- [F1]These shares were sold in compliance with a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.545 to $16.955 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F3]Ten percent (10%) of the shares subject to the option vested on February 19, 2015, Twenty-five percent (25%) of the shares subject to the option vested on November 1, 2015, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Documents
Issuer
Neuronetics, Inc.
CIK 0001227636
Entity typeother
Related Parties
1- filerCIK 0001744956
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 6:26 PM ET
- Size
- 9.5 KB